Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer

• Published in: Journal of ovarian research 2023-04, Vol.16 (1), p.82-82, Article 82
• Main Authors: Nie, Sipei, Ni, Na, Chen, Ningxin, Gong, Min, Feng, Ercui, Liu, Jinhui, Liu, Qiaoling
• Format: Article
• Language: English
• Subjects: Algorithms; Apoptosis; Bioinformatics; Bioinformatics analysis; Cancer therapies; CD4 antigen; CD8 antigen; Cell death; Cisplatin; Correlation analysis; DNA methylation; Female; Gene expression; Genes; Genomes; Genomics; Humans; Immune checkpoint inhibitors; Immune status; Immunological memory; Lymphocytes T; Macrophages; Medical prognosis; Memory cells; Mesothelioma; Metastases; Metastasis; Mutation; Necroptosis; Necroptosis-related gene; Ovarian cancer; Ovarian Neoplasms; Paclitaxel; Patients; Prognosis; Regression analysis; Risk assessment; Risk Factors; Risk groups; Stat4 protein; Transcription factors; Tumor Microenvironment; Tumors
• ISSN: 1757-2215; 1757-2215
• DOI: 10.1186/s13048-023-01155-9

Necroptosis is a novel type of programmed cell death distinct from apoptosis. However, the role of necroptosis in ovarian cancer (OC) remains unclear. The present study investigated the prognostic value of necroptosis-related genes (NRGs) and the immune landscape in OC. The gene expression profiling and clinical information were downloaded from the TCGA and GTEx databases. Differentially expressed NRGs (DE-NRGs) between OC and normal tissueswere identified. The regression analyses were conducted to screen the prognostic NRGs and construct the predictive risk model. Patients were then divided into high- and low-risk groups, and the GO and KEGG analyses were performed to explore bioinformatics functions between the two groups. Subsequently, the risk level and immune status correlations were assessed through the ESTIMATE and CIBERSORT algorithms. The tumor mutation burden (TMB) and the drug sensitivity were also analyzed based on the two-NRG signature in OC. Totally 42 DE-NRGs were identified in OC. The regression analyses screened out two NRGs (MAPK10 and STAT4) with prognostic values for overall survival. The ROC curve showed a better predictive ability in five-year OS using the risk score. Immune-related functions were significantly enriched in the high- and low-risk group. Macrophages M1, T cells CD4 memory activated, T cells CD8, and T cells regulatory infiltration immune cells were associated with the low-risk score. The lower tumor microenvironment score was demonstrated in the high-risk group. Patients with lower TMB in the low-risk group showed a better prognosis, and a lower TIDE score suggested a better immune checkpoint inhibitor response in the high-risk group. Besides, cisplatin and paclitaxel were found to be more sensitive in the low-risk group. MAPK10 and STAT4 can be important prognosis factors in OC, and the two-gene signature performs well in predicting survival outcomes. Our study provided novel ways of OC prognosis estimation and potential treatment strategy.